您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2026, Vol. 64 ›› Issue (7): 11-27.doi: 10.6040/j.issn.1671-7554.0.2025.1148

• 基础医学 • 上一篇    下一篇

大黄素治疗糖尿病肾病的网络药理学

尹丹丹1,彦名南2,韩净净3,张伟4,崔学雷5,刘亚平6,石书龙6,季宗文6   

  1. 1.济宁医学院临床医学院(附属医院), 山东 济宁 272067;2.山东第一医科大学附属济宁市第一人民医院, 山东 济宁 272011;3.济宁市第一人民医院血液内科, 山东 济宁 272011;4.济宁市第一人民医院消化内科, 山东 济宁 272011;5.高青县高城中心卫生院中医科, 山东 高青 256301;6.济宁市第一人民医院内分泌科, 山东 济宁 272011
  • 出版日期:2026-07-10 发布日期:2026-07-21
  • 通讯作者: 季宗文. E-mail:13562412687@163.com
  • 基金资助:
    济宁市重点研发计划项目(2024YXNS245)

Network pharmacology of emodin in the treatment of diabetic kidney disease

YIN Dandan1, YAN Mingnan2, HAN Jingjing3, ZHANG Wei4, CUI Xuelei5, LIU Yaping6, SHI Shulong6, JI Zongwen6   

  1. 1. Jining Medical University Clinical Medical College(Affiliated Hospital), Jining 272067, Shandong, China;
    2. Jining NO.1 Peoples Hospital Affiliated to Shandong NO.1 Medical University, Jining 272011, Shandong, China;
    3. Department of Hematology, Jining NO.1 Peoples Hospital, Jining 272011, Shandong, China;
    4. Department of Gastroenterology, Jining NO.1 Peoples Hospital, Jining 272011, Shandong, China;
    5. Department of Traditional Chinese Medicine, Gaocheng Central Health Center, Gaoqing 256301, Shandong, China;
    6. Department of Endocrinology, Jining NO.1 Peoples Hospital, Jining 272011, Shandong, China
  • Online:2026-07-10 Published:2026-07-21

摘要: 目的 基于网络药理学、分子对接技术及体外细胞实验探究大黄素治疗糖尿病肾病的作用机制。 方法 利用公共数据库获取大黄素和糖尿病肾病的交集靶点,建立蛋白-蛋白互作网络,对所得靶点进行基因本体(gene ontology, GO)、京都基因和基因组百科全书(Kyoto encyclopedia of genes and genomes, KEGG)功能富集分析,对大黄素与核心治疗靶点进行分子对接及分子动力学模拟。将小鼠肾足细胞(mouse podocyte clone-5, MPC-5)分为对照组、高糖组和大黄素干预组,大黄素干预组分别给予5、10、20、40 μmol/L的大黄素干预24 h,检测细胞活力、铁离子、相关基因表达水平。进行非靶向代谢组学分析,筛选差异代谢物。 结果 获得80个大黄素治疗糖尿病肾病的潜在作用靶点,其中核因子E2相关因子2(nuclear factor erythroid 2-related factor 2, NRF2)是关键治疗靶点。GO分析获得190条生物过程、80条细胞组成、100条分子功能。KEGG富集分析得到铁死亡、脂质与动脉粥样硬化、白细胞介素-17(interleukin-17, IL-17)等信号通路。大黄素与NRF2之间存在强而稳定的相互作用,结合构象稳定。大黄素可显著改善高糖诱导的细胞损伤;10 μmol/L大黄素干预后,细胞内铁离子水平、肿瘤坏死因子(tumor necrosis factor, TNF)、IL-17的表达降低,铁死亡核心标志物谷胱甘肽过氧化物酶4(glutathione peroxidase 4, GPX4)、NRF2及其下游相关基因的mRNA表达升高(P<0.001)。代谢组学分析显示,大黄素干预后共鉴定出29种差异代谢物,其中10种上调、19种下调。 结论 大黄素通过关键靶点NRF2协同调控铁死亡、IL-17等多条信号通路,发挥抗铁死亡、抗炎及代谢调节作用,从而实现对糖尿病肾病的肾脏保护作用。

关键词: 大黄素, 核因子E2相关因子2, 铁死亡信号通路, 糖尿病肾病, 网络药理学

中图分类号: 

  • R285.5
[1] 张俊清, 苏白海, 张捷, 等. 糖尿病肾脏疾病早期预测与诊断专家共识[J]. 中华内科杂志, 2021, 60(6): 522-532. Zhang Junqing, Su Baihai, Zhang Jie, et al. Expert consensus on early prediction and diagnosis of diabetic kidney disease[J]. Chinese Journal of Internal Medicine, 2021, 60(6): 522-532.
[2] Zhang L X, Long J Y, Jiang W S, et al. Trends in chronic kidney disease in China[J]. N Engl J Med, 2016, 375(9): 905-906.
[3] 杜宇彤, 周佳丽, 栗宇, 等. 大黄有效成分干预糖尿病肾病的机制研究进展[J]. 辽宁中医药大学学报, 2025, 27(10): 182-186. Du Yutong, Zhou Jiali, Li Yu, et al. Research progress on the mechanism of Dahuang(rhei Radix et rhizoma)active components in intervening diabetic nephropathy[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2025, 27(10): 182-186.
[4] Alicic R Z, Rooney M T, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities[J]. Clin J Am Soc Nephrol, 2017, 12(12): 2032-2045.
[5] Tziomalos K, Athyros V G. Diabetic nephropathy: new risk factors and improvements in diagnosis[J]. Rev Diabet Stud, 2015, 12(1/2): 110-118.
[6] Salami M, Salami R, Mafi A, et al. Therapeutic potential of resveratrol in diabetic nephropathy according to molecular signaling[J]. Curr Mol Pharmacol, 2022, 15(5): 716-735.
[7] Zheng X Y, Yang S M, Zhang R, et al. Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes[J]. Drug Des Devel Ther, 2019, 13: 3171-3180. DOI:10.2147/DDDT.S204958
[8] Wang S, Huang X F, Zhang P, et al. Chronic Rhein treatment improves recognition memory in high-fat diet-induced obese male mice[J]. J Nutr Biochem, 2016, 36: 42-50. DOI:10.1016/j.jnutbio.2016.07.008.
[9] Xu S Z, Lv Y Y, Zhao J, et al. The inhibitory effect of Rhein on proliferation of high glucose-induced mesangial cell through cell cycle regulation and induction of cell apoptosis[J]. Pharmacogn Mag, 2016, 12(Suppl 2): S257-S263.
[10] Tu Y, Gu L B, Chen D P, et al. Rhein inhibits autophagy in rat renal tubular cells by regulation of AMPK/mTOR signaling[J]. Sci Rep, 2017, 7: 43790. DOI: 10.1038/srep43790
[11] Fu S J, Zhou Y N, Hu C, et al. Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy[J]. BMC Complement Med Ther, 2022, 22(1): 210. DOI: 10.1186/s12906-022-03662-6
[12] 陈宇航, 丁雷, 魏然, 等. 基于网络药理学和生物信息学探讨鼻敏方调节铁死亡治疗变应性鼻炎的作用[J]. 中国中西医结合耳鼻咽喉科杂志, 2025, 33(4): 254-261. Chen Yuhang, Ding Lei, Wei Ran, et al. Differential gene analysis of ferroptosis in the treatmentof allergic rhinitis with Bi-Min-Formul based on GEO using network pharmacology and molecular docking[J]. Chinese Journal of Otorhinolaryngology in Integrative Medicine, 2025, 33(4): 254-261.
[13] 李明波, 黄燕波, 刘俊城, 等. 黄芪桂枝五物汤治疗强直性脊柱炎的网络药理学探讨[J]. 山东大学学报(医学版), 2022, 60(3): 29-38. Li Mingbo, Huang Yanbo, Liu Juncheng, et al. Exploration of Huangqi Guizhi Wuwutang in the treatment of ankylosing spondylitis based on network pharmacology[J]. Journal of Shandong University(Health Sciences), 2022, 60(3): 29-38.
[14] Shayo M J, Samwel B, Shadrack D M, et al. Drug repositioning identifies salvinorin A and deacetylgedunin(DCG)enriched plant extracts as novel inhibitors of Mpro, RBD-ACE2 and TMPRRS2 proteins[J]. RSC Adv, 2024, 14(29): 21203-21212.
[15] 张文顺, 曲超, 石岩, 等. 基于分子对接技术、分子动力学模拟中药复方益糖康防治糖尿病肾病作用机制研究[J]. 辽宁中医药大学学报, 2022, 24(2): 107-114.
[16] 章玉婷,王安慧, 杨晋妮, 等. 非酒精性脂肪性肝病细胞模型中胆固醇代谢紊乱机制[J]. 中国药科大学学报, 2023, 54(4): 490-500. Zhang Yuting, Wang Anhui, Yang Jinni, et al. Mechanism of cholesterol metabolic disorder in a cell model of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2023, 54(4): 490-500.
[17] 薛华, 何雨昕, 郭子旭, 等. 基于UHPLC-QTOF-MS探讨高原鼠兔棕色脂肪低氧环境代谢分子机制[J]. 重庆医科大学学报, 2025, 50(2): 267-274. Xue Hua, He Yuxin, Guo Zixu, et al. Molecular mechanism of brown adipose tissue metabolism in the hypoxic environment in plateau pikas: a study based on ultra-performance liquid chromatography-quadruple time-of-flight mass spectrometry[J]. Journal of Chongqing Medical University, 2025, 50(2): 267-274.
[18] Zhao D M, Zhong R, Wang X T, et al. Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine[J]. Front Endocrinol, 2024, 15: 1429420. DOI:10.3389/fendo.2024.1429420
[19] Patti G J, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy[J]. Nat Rev Mol Cell Biol, 2012, 13(4): 263-269.
[20] 何文秀, 王吉文, 杨联林, 等. 基于网络药理学和代谢组学与分子对接技术预测鱼腥草破壁饮片抗辐射质量标志物[J]. 中成药, 2025, 47(3): 1014-1023.
[21] 张雄宝, 陈佳晖, 傅亚婷, 等. 基于血清代谢组学分析热习服相关代谢产物及通路特征[J]. 海军军医大学学报, 2024, 45(5): 569-577. Zhang Xiongbao, Chen Jiahui, Fu Yating, et al. Analysis of heat acclimatization related metabolites and pathway characteristics based on serum metabonomics[J]. Academic Journal of Naval Medical University, 2024, 45(5): 569-577.
[22] Wu C W, Cao L, Liu M, et al. Exploring the mechanisms underlying the therapeutic effect of the drug pair Rhubarb-Coptis in diabetic nephropathy using network pharmacology and molecular docking analysis[J]. Ann Transl Med, 2022, 10(24):1343. DOI:10.21037/atm-22-5550
[23] 庄延双, 蔡宝昌, 张自力. 网络药理学在中药研究中的应用进展[J]. 南京中医药大学学报, 2021, 37(1): 156-160.
[24] Merecz-Sadowska A, Sadowski A, Zielińska-Bli zniewska H, et al. Network pharmacologyas a tool to investigate the antioxidant and anti-inflammatory potential of plant secondary metabolites-a review and perspectives[J]. Int J Mol Sci, 2025, 26(14). DOI:10.3390/ijms26146678
[25] Du B X, Fu Q, Yang Q, et al. Different types of cell death and their interactions in myocardial ischemia-reperfusion injury[J]. Cell Death Discov, 2025, 11(1): 87-105.
[26] Hu J Q, Gu W J, Ma N, et al. Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway[J]. Br J Pharmacol, 2022, 179(15): 3991-4009.
[27] Feng Q, Yang Y, Qiao YJ, et al. Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2/HO-1 signaling pathway[J]. Am J Chin Med, 2023, 51(4): 997-1018.
[28] Xue M J, Tian Y W, Zhang H, et al. Curcumin nanocrystals ameliorate ferroptosis of diabetic nephropathy through glutathione peroxidase 4[J]. Front Pharmacol, 2024, 15: 1508312. DOI:10.3389/fphar.2024.1508312
[29] Chu J Y, Wang K W, Lu L L, et al. Advances of iron and ferroptosis in diabetic kidney disease[J]. Kidney Int Rep, 2024, 9(7): 1972-1985.
[30] 范晓艳, 王元耕, 陈泽涛. 黄芪桂枝五物汤治疗心衰的网络药理学机制[J]. 山东大学学报(医学版), 2022, 60(11): 70-81. Fan Xiaoyan, Wang Yuangeng, Chen Zetao. Network pharmacologic mechanism of Huangqi Guizhi Wuwu Decoction in treating heart failure[J]. Journal of Shandong University(Health Sciences), 2022, 60(11): 70-81.
[31] Hayes J D, Dinkova-Kostova A T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism[J]. Trends Biochem Sci, 2014, 39(4): 199-218.
[32] 张钦媛, 陈彦旭, 秦大凯, 等. 中药调控Nrf2信号通路干预糖尿病肾病研究进展[J]. 中国实验方剂学杂志, 2025, 31(18): 277-285.
[33] Wang J, Peng X J, Zhang X Y, et al. Design, synthesis, and evaluation of nitroxide radical derivatives based on Rhein as potential anti-aging agents targeting the Keap1-Nrf2 pathway[J]. Drug Des Devel Ther, 2025, 19: 5153-5167. DOI: 10.2147/DDDT.S516209
[34] 李星桥, 夏烨, 刘波. 头手足三联针法基于NrF2/SLC7A11调控铁死亡治疗大鼠缺血性脑卒中机制研究[J]. 辽宁中医药大学学报, 2025, 27(2): 200-205. Li Xingqiao, Xia Ye, Liu Bo. Mechanism of head-hand-foot tripleacupuncture kinesitherapy based on NrF2/SLC7A11 regulating ferroptosis in the treatment of ischemic stroke in rats[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2025, 27(2): 200-205.
[35] 赵雅, 冯萧, 张存钰, 等. 疮灵液通过Nrf2/SLC7A11/GPX4信号通路调控铁死亡改善糖尿病足溃疡的作用及机制研究[J]. 南京中医药大学学报, 2025, 41(10): 1344-1355. Zhao Ya, Feng Xiao, Zhang Cunyu, et al. Chuangling Ye ameliorates diabetic foot ulcers by regulating ferroptosis via the Nrf2/SLC7A11/GPX4 signaling pathway:mechanisms and therapeutic effects[J]. Journal of Nanjing University of Traditional Chinese Medicine, 2025, 41(10): 1344-1355.
[36] Shen G, Wen H Y, Li H J, et al. Emodin protects against severe acute pancreatitis-associated acute lung injury by activating Nrf2/HO-1/GPX4 signal and inhibiting ferroptosis in vivo and in vitro[J]. BMC Gastroenterol, 2025, 25(1): 57. DOI: 10.1186/s12876-025-03660-1
[37] Li J C, Lu K M, Sun F L, et al. Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway[J]. J Transl Med, 2021, 19(1): 96. DOI:10.1186/s12967-021-02745-1
[38] Yuan Z N, Wang X Y, Qin B Y, et al. Targeting NQO1 induces ferroptosis and triggers anti-tumor immunity in immunotherapy-resistant KEAP1-deficient cancers[J]. Drug Resist Updat, 2024, 77:101160. DOI:10.1016/j.drup.2024.101160
[39] Chen J Y, Li X P, Ge C D, et al. The multifaceted role of ferroptosis in liver disease[J]. Cell Death Differ, 2022, 29(3): 467-480.
[40] Liu H, Zhang T A, Zhang W Y, et al. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway[J]. Exp Neurol, 2023, 369: 114541. DOI:10.1016/j.expneurol.2023.114541
[41] 刘法, 韩丹, 徐梓威, 等. 萝卜硫素对糖尿病视网膜病变大鼠铁死亡途径和铁稳态的影响[J]. 眼科新进展, 2025, 45(11): 870-882. Liu Fa, Han Dan, Xu Ziwei, et al. Effects of sulforaphane on the ferroptosis pathway and iron homeostasis in rats with diabetic retinopathy[J]. Recent Advances in Ophthalmology, 2025, 45(11): 870-882.
[42] 刘友霞, 刘毅, 曹铭锋, 等. 大黄素对高糖环境下系膜细胞收缩功能的影响[J]. 山东大学学报(医学版), 2010, 48(9): 14-18. Liu Youxia, Liu Yi, Cao Mingfeng, et al. Effect of emodin on the systolic function of mesangial cells in high glucose environment[J]. Journal of Shandong University(Health Sciences), 2010, 48(9): 14-18.
[43] 范立荣, 李松林, 李函舟, 等. 基于Nrf2/HO-1信号通路探讨三黄益肾胶囊对糖尿病肾病大鼠氧化应激的影响[J]. 天津中医药, 2025, 42(3): 381-386. Fan Lisong, Li Songlin, Li Hanzhou, et al. Effect of Sanhuang Yishen Capsule on oxidative stress in rats with diabetic nephropathy based on Nrf2/HO-1 signaling pathway[J]. Tianjin Journal of Traditional Chinese Medicine, 2025, 42(3): 381-386.
[44] Zeng P, Wang X M, Ye C Y, et al. Mechanistic insights into the anti-depressant effect of emodin: an integrated systems pharmacology study and experimental validation[J]. Aging, 2021, 13(11):15078-15099.
[45] Li Q Q, Gao J, Pang X H, et al. Molecular mechanisms of action of emodin: as an anti-cardiovascular disease drug[J]. Front Pharmacol, 2020, 11: 559607. DOI: 10.3389/fphar.2020.559607
[46] 赵进喜, 王世东, 傅强, 等. 吕仁和教授诊治糖尿病与肾病学术思想与传承[J]. 现代中医临床, 2016, 23(3): 1-3. Zhao Jinxi, Wang Shidong, Fu Qiang, et al. Academic idea and inheritance of Professor Lü Renhes experience for treating diabetes and kidney disease[J]. Modern Chinese Clinical Medicine, 2016, 23(3): 1-3.
[47] 李颖娟, 任婉婷, 刘新艳. 铁死亡的相关机制及其对糖尿病肾病影响的研究进展[J]. 中国医药导报, 2024, 21(13): 184-187. Li Yingjuan, Ren Wanting, Liu Xinyan. Research progress on the mechanism of ferroptosiand its effect on diabetic nephropathy[J]. China Medical Herald, 2024, 21(13): 184-187.
[48] Chatgilialoglu C. Biomarkers of oxidative and radical stress[J]. Biomolecules, 2024, 14(2): 194-200.
[49] Gu X Y, Huang Z C, Ying X, et al. Ferroptosis exacerbates hyperlipidemic acute pancreatitis by enhancing lipid peroxidation and modulating the immune microenvironment[J]. Cell Death Discov, 2024, 10(1): 242-231.
[50] Jiang X J, Stockwell B R, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J].Nat Rev Mol Cell Biol, 2021, 22(4): 266-282.
[51] Li L, Zhu ZJ. Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis[J]. Front Pharmacol, 2022, 13: 1071844.DOI:10.3389/fphar.2022.1071844
[1] 张翰之,陈雯,梁启惠,丁胜勇,吴海萃. lncNEAT1通过ceRNA网络调控细胞氧化应激损伤的机制与研究进展[J]. 山东大学学报 (医学版), 2026, 64(7): 100-117.
[2] 杜学识,倪向敏,梁馨予,白倩,朱文艺,王建. 雌马酚对DN的保护作用及潜在靶点[J]. 山东大学学报 (医学版), 2024, 62(8): 49-58.
[3] 王莉莎,王上增,史栋梁,张仲博,任博文,王云飞,郭中华,周晓宁. 乌头汤对膝骨关节炎大鼠模型的治疗作用[J]. 山东大学学报 (医学版), 2024, 62(5): 64-71.
[4] 闫小龙,秦英,邵将,陈东峰,管东辉,赵灿斌. 姜黄素通过Wnt/β-catenin信号通路调控骨形成的机制[J]. 山东大学学报 (医学版), 2024, 62(10): 76-86.
[5] 刘洋,陈贵海. 寒痉汤对冷刺激诱导主动脉平滑肌细胞氧化应激的影响及机制[J]. 山东大学学报 (医学版), 2023, 61(8): 24-30.
[6] 李明波,黄燕波,刘俊城,任东成,谭成双,徐继禧,丁金勇. 黄芪桂枝五物汤治疗强直性脊柱炎的网络药理学探讨[J]. 山东大学学报 (医学版), 2022, 60(3): 29-38.
[7] 范晓艳,王元耕,陈泽涛. 黄芪桂枝五物汤治疗心衰的网络药理学机制[J]. 山东大学学报 (医学版), 2022, 60(11): 70-81.
[8] 于莹,张功,刘晶,颜世童,韩涛,黄海量. 基于网络药理学和分子对接方法探析黄芪预防新型冠状病毒肺炎的潜在作用机制[J]. 山东大学学报 (医学版), 2021, 59(4): 6-16.
[9] 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14.
[10] 熊艺璇,赵斌,贾凌璐,张文静,徐欣. 姜黄素通过Nrf2信号通路促进炎症状态下牙周膜干细胞的成骨分化[J]. 山东大学学报 (医学版), 2020, 58(5): 19-26.
[11] 丁华琳,李扬扬,于丰源,战伟伟,于苏国. 达格列净通过Klotho/TGF-β1通路抑制糖尿病肾病大鼠肾纤维化的作用[J]. 山东大学学报 (医学版), 2020, 58(3): 75-80.
[12] 高源,季伟,肖丹,刘井,彭丹冰,季春. 基于网络药理学预测沙苑子的抗炎作用机制[J]. 山东大学学报 (医学版), 2019, 57(9): 59-68.
[13] 陈欧,李国勇,刘爱红,朱晓波,陈少杰,王一彪. 网络药理学预测麻黄治疗哮喘的抗炎作用机制[J]. 山东大学学报 (医学版), 2019, 57(1): 55-61.
[14] 史培堃,曾贝妮,吴伟芳,胡晓燕,马天加,周亚滨. Keap1在肾细胞癌中的表达及其作用[J]. 山东大学学报(医学版), 2017, 55(3): 94-99.
[15] 陈志新,王颖,曹新冉, 黑乃豪,李俊龙,董波,关广聚. 非肽类Ang(1-7)受体激动剂AVE0991对大鼠糖尿病肾病的保护作用[J]. 山东大学学报(医学版), 2016, 54(10): 29-33.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!